ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are 1) Cholesterol Efflux MediatorTM, VAR 200...
The biotech sector has been hot this year with multiple stocks making impressive runs. One biotech stock that appears to be poised to have a substantial run soon is ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) which could be a sympathy play to another biotech stock – First Wave BioPharma, Inc. (NASDAQ: FWBI). While FWBI stock climbed by as much as 157% on news of...